Your browser doesn't support javascript.
loading
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
O'B Hourihane, Jonathan; Beyer, Kirsten; Abbas, Allyah; Fernández-Rivas, Montserrat; Turner, Paul J; Blumchen, Katharina; Nilsson, Caroline; Ibáñez, Maria D; Deschildre, Antoine; Muraro, Antonella; Sharma, Vibha; Erlewyn-Lajeunesse, Michel; Zubeldia, José Manuel; De Blay, Frederic; Sauvage, Christine D; Byrne, Aideen; Chapman, John; Boralevi, Franck; DunnGalvin, Audrey; O'Neill, Charmaine; Norval, David; Vereda, Andrea; Skeel, Ben; Adelman, Daniel C; du Toit, George.
Afiliação
  • O'B Hourihane J; Paediatrics and Child Health, Royal College of Surgeons in Ireland, Dublin, Ireland; Paediatrics and Child Health, INFANT Centre and HRB Clinical Research Facility, University College Cork, Cork, Ireland.
  • Beyer K; Department of Pediatric Pneumology, Immunology and Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Abbas A; Aimmune Therapeutics, London, UK.
  • Fernández-Rivas M; Hospital Clínico San Carlos, UCM, IDISSC, ARADyAL, Madrid, Spain.
  • Turner PJ; Imperial College, London, London, UK.
  • Blumchen K; Department of Children and Adolescent Medicine, Division of Allergology, Pneumology and Cystic Fibrosis, Goethe University Frankfurt, Frankfurt, Germany.
  • Nilsson C; Clinical Science and Education, Karolinska Institutet, Sachs' Children and Youth Hospital, Sodersjukhuset, Stockholm, Sweden.
  • Ibáñez MD; H. Infantil Universitario Niño Jesús, ARADyAL-RETICs Instituto de Salud Carlos III, IIS-P, FibHNJ, Madrid, Spain.
  • Deschildre A; Université de Lille, CHU Lille, Pediatric Pulmonology and Allergy Unit, Hôpital Jeanne de Flandre, Lille, France.
  • Muraro A; Food Allergy Referral Centre Veneto Region, Department of Woman and Child Health, Padua University Hospital, Padua, Italy.
  • Sharma V; Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust and Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
  • Erlewyn-Lajeunesse M; University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Zubeldia JM; Hospital GU Gregorio Marañón, and Biomedical Research Network on Rare Diseases, Madrid, Spain.
  • De Blay F; University Hospital Strasbourg, Strasbourg, France.
  • Sauvage CD; Hôpital Saint-Vincent, Saint Antoine, Lille, France.
  • Byrne A; National Children's Research Centre, Dublin, Ireland.
  • Chapman J; James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK.
  • Boralevi F; CIC 1401, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • DunnGalvin A; Paediatrics and Child Health, Royal College of Surgeons in Ireland, Dublin, Ireland; Department of Pediatrics and Pediatric Infectious Diseases, Sechenov University, Moscow, Russia.
  • O'Neill C; Aimmune Therapeutics, London, UK.
  • Norval D; Aimmune Therapeutics, London, UK.
  • Vereda A; Aimmune Therapeutics, London, UK.
  • Skeel B; Aimmune Therapeutics, London, UK.
  • Adelman DC; Aimmune Therapeutics, Brisbane, CA, USA; Department of Medicine, University of California San Francisco, San Francisco, CA, USA. Electronic address: dadelman@aimmune.com.
  • du Toit G; Evelina London, Children's Allergy Service, Guy's and St Thomas' Hospital, London, UK; Department of Women and Children's Health (Paediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Lancet Child Adolesc Health ; 4(10): 728-739, 2020 10.
Article em En | MEDLINE | ID: mdl-32702315
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Alérgenos / Dessensibilização Imunológica / Hipersensibilidade a Amendoim Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Alérgenos / Dessensibilização Imunológica / Hipersensibilidade a Amendoim Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article